Fetal biometry following in-utero exposure to dolutegravir-based or efavirenz-based antiretroviral therapy

被引：2
|
作者：
Banda, Francis M. [1 ]
Powis, Kathleen M. [2 ,3 ,4 ,5 ]
Sun, Shan [6 ]
Makhema, Joseph [2 ]
Masasa, Gosego [2 ]
Yee, Lynn M. [7 ]
Jao, Jennifer [2 ,8 ,9 ]
机构：
[1] Univ Botswana, Dept Paediat & Adolescent Hlth, Fac Med, P Bag 00713, Gaborone, Botswana
[2] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana
[3] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA
[4] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA
[6] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA
[7] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA
[8] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA
[9] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
AIDS | 2020年 / 34卷 / 15期
关键词：
D O I：
10.1097/QAD.0000000000002674
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2336 / 2337
页数：2
相关论文
共 50 条
  • [31] Birth Defects After Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy: A Multicohort Analysis
    de Tejada, Begona Martinez
    Gayet-Ageron, Angele
    Winterfeld, Ursula
    Favarato, Graziella
    Thorne, Claire
    Goetghebuer, Tessa
    Scherpbier, Henriette
    Bailey, Heather
    Malyuta, Ruslan
    Volokha, Alla
    Prieto, Luis
    Ramos, Jose Tomas
    Kahlert, Christian Raphael
    Polli, Christian
    Mendoza-Palomar, Natalia
    Coll, Maria Teresa
    Noguera-Julian, Antoni
    Peters, Helen
    Gingaras, Cosmina
    Le Coeur, Sophie
    Giaquinto, C.
    Rampon, O.
    Mazza, A.
    De Rossi, A.
    Worner, I. Grosch
    Kreyenbroek, M.
    Godfried, M. H.
    Nellen, F. J. B.
    van Leeuwen, L.
    Naver, L.
    Bohlin, A. B.
    Lindgren, S.
    Kaldma, A.
    Belfrage, E.
    Levy, J.
    Barlow, P.
    Manigart, Y.
    Hainaut, M.
    Vandercam, B.
    Brichard, B.
    Van der Linden, D.
    Waterloos, H.
    Viscoli, C.
    De Maria, A.
    Bentivoglio, G.
    Ferrero, S.
    Gotta, C.
    Valerius, N. H.
    Rosenfeldt, V.
    Savasi, V.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 80 (03) : 316 - 324
  • [32] Comparative effectiveness of bictegravir versus dolutegravir, raltegravir, and efavirenz-based antiretroviral therapy among treatment-naïve individuals with HIV
    Nunez, Isaac
    Caro-Vega, Yanink
    Macdonald, Conor
    Mosqueda, Juan Luis
    Pineirua-Menendez, Alicia
    Matthews, Anthony A.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2025, 133 : 86 - 92
  • [33] Metabolic Syndrome Among People Living With HIV on Dolutegravir and Efavirenz-Based Antiretroviral Therapy in Ethiopia: A Comparative Cross-Sectional Study
    Jemal, Mohammed
    Ashenef, Baye
    Sinamaw, Deresse
    Adugna, Adane
    Getinet, Mamaru
    Baylie, Temesgen
    Waritu, Nuredin Chura
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2024, 23
  • [34] Is treatment emergent weight gain on dolutegravir-based antiretroviral therapy reversible following discontinuation? A retrospective cohort study
    Ring, K.
    Freeman, C.
    Weston, R.
    Fidler, S.
    Mackie, N.
    HIV MEDICINE, 2020, 21 : 24 - 24
  • [35] Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy
    Boulle, Andrew
    Van Cutsem, Gilles
    Cohen, Karen
    Hilderbrand, Katherine
    Mathee, Shaheed
    Abrahams, Musaed
    Goemaere, Eric
    Coetzee, David
    Maartens, Gary
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (05): : 530 - 539
  • [36] Sex-Based Disparities in the Transition to Dolutegravir-Based Antiretroviral Therapy in West African HIV Cohorts
    Tiendrebeogo, Thierry
    Malateste, Karen
    Poda, Armel
    Minga, Albert
    Messou, Eugene
    Chenal, Henri
    Ezechi, Oliver
    Ekouevi, Didier K.
    Ofotokun, Igho
    Jaquet, Antoine
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (05):
  • [37] Dolutegravir/elvitegravir/raltegravirCongenital malformations following in-utero exposure: 6 case reports
    Reactions Weekly, 2019, 1769 (1) : 173 - 173
  • [38] Efavirenz-based combination antiretroviral therapy after peripartum single-dose nevirapine
    Bolhaar, M. G.
    Karstaedt, A. S.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (01) : 38 - 42
  • [39] Experience of dolutegravir-based antiretroviral treatment and risks of diabetes mellitus
    Hirigo, Agete Tadewos
    Gutema, Selamawit
    Eifa, Aberash
    Ketema, Worku
    SAGE OPEN MEDICAL CASE REPORTS, 2022, 10
  • [40] PethidineIntense fetal bradycardia following in-utero exposure: case report
    Reactions Weekly, 2016, 1591 (1) : 143 - 143
12345